Cargando…

Hydroxychloroquine and Myasthenia Gravis-Can One Take This Risk?

Detalles Bibliográficos
Autores principales:	Elavarasi, Arunmozhimaran, Goyal, Vinay
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Wolters Kluwer - Medknow 2020
Materias:	Letters to the Editor
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7313600/ https://www.ncbi.nlm.nih.gov/pubmed/32606531 http://dx.doi.org/10.4103/aian.AIAN_363_20

Ejemplares similares

Reply to the Letter to Editor by Lacout and colleagues: Chloroquine and Hydroxychloroquine for the Treatment of COVID-19: a Systematic Review and Meta-analysis
por: Prasad, Manya, et al.
Publicado: (2021)

Neuropsychiatric Lupus: The Devil is in the Detail
por: Elavarasi, Arunmozhimaran, et al.
Publicado: (2019)

Myasthenia gravis: A challenge
por: Ramesh, Bhagyalakshmi
Publicado: (2015)

Subgroup Classification of Myasthenia Gravis
por: Renjen, Pushpendra N.
Publicado: (2021)

MuSK-Myasthenia Gravis Unmasked by Hydroxychloroquine
por: Bhaskar, Shalini, et al.
Publicado: (2022)

Nephrotic syndrome after thymectomy for myasthenia gravis
por: Kute, V. B., et al.
Publicado: (2013)

The perianaesthetic management of a patient with myasthenia gravis
por: Singh, Anisha, et al.
Publicado: (2023)

Management of thoracoscopic thymectomy in a myasthenia gravis patient
por: Adate, Kavita, et al.
Publicado: (2011)

Long-term treatment of refractory myasthenia gravis with subcutaneous immunoglobulin
por: Kovács, Edina, et al.
Publicado: (2017)

Subcutaneous Immunoglobulins are a Valuable Treatment Option in Myasthenia Gravis
por: Garnero, Martina, et al.
Publicado: (2018)

Favipiravir Experience in Covid-19 Positive Myasthenia Gravis Patients
por: Yevgi, Recep, et al.
Publicado: (2021)

New-Onset Myasthenia Gravis Following COVID-19 Vaccination
por: Özenç, Betül, et al.
Publicado: (2022)

Management of Raised Intracranial Pressure—When Three is Better than Two
por: Bansal, Bhavik, et al.
Publicado: (2022)

Sweet taste loss in myasthenia gravis: more than a coincidence?
por: Chabwine, Joelle N, et al.
Publicado: (2014)

Myasthenia Gravis Associated with Acute Hepatitis E Infection in Immunocompetent Woman
por: Belbezier, Aude, et al.
Publicado: (2014)

Refractory Myasthenia Gravis Treated Successfully with Rituximab: A Case Report
por: Rahul, L Yadav, et al.
Publicado: (2017)

Electronic health record derived-impact of COVID-19 on myasthenia gravis
por: Roy, Bhaskar, et al.
Publicado: (2021)

Polymyositis with too Many Associations: A Paraneoplastic Syndrome
por: Elavarasi, Arunmozhimaran, et al.
Publicado: (2018)

Vanishing Brain Lesions in a Patient with Vision Loss and Ataxia: A Case of CNS Lymphoma with Corticosteroid Related Regression
por: Elavarasi, Arunmozhimaran, et al.
Publicado: (2022)

Hydroxychloroquine in COVID-19: Taking care of statistics to take care of patients
por: Brito-Azevedo, Anderson
Publicado: (2020)

Dancing Scapula: The Missed Movement
por: Elavarasi, Arunmozhimaran, et al.
Publicado: (2019)

Burden of disease in myasthenia gravis: taking the patient’s perspective
por: Lehnerer, Sophie, et al.
Publicado: (2021)

Emergency cesarian section in a patient of myasthenia gravis: Is neuraxial anesthesia safe?
por: Mundada, Surbhi D., et al.
Publicado: (2012)

Emergence of Myasthenia Gravis with Myositis in a Patient Treated with Pembrolizumab for Thymic Cancer
por: Huh, So-Young, et al.
Publicado: (2018)

Oculopharyngeal muscular dystrophy misdiagnosed as myasthenia gravis: Case report and review of literature
por: Aryani, Omid, et al.
Publicado: (2017)

Clinical characteristics and outcomes of patients with overlapping Miller Fisher syndrome and myasthenia gravis
por: Yuan, Jun-Liang, et al.
Publicado: (2019)

Interplay between Myasthenia Gravis and Severe COVID-19 Infection: The Missing Links
por: Singh, Shalendra, et al.
Publicado: (2022)

Hydroxychloroquine: Aggravation of myasthenia gravis following off label use: case report
Publicado: (2020)

Seronegative Myasthenia Gravis in Association with Human T-Lymphotropic Virus Type 1 and Hepatitis C
por: Amin, Saad Muhammad, et al.
Publicado: (2019)

Bortezomib in severe MuSK-antibody positive myasthenia gravis: first clinical experience
por: Schneider-Gold, Christiane, et al.
Publicado: (2017)

Systemic Lupus Erythematosus and Myasthenia Gravis in a Male Patient: an HLA Case Investigated
por: Klimi, Eleni, et al.
Publicado: (2021)

Correction to: Burden of disease in myasthenia gravis: taking the patient’s perspective
por: Lehnerer, Sophie, et al.
Publicado: (2022)

Management of myasthenia gravis during pregnancy
por: Bansal, Ramandeep, et al.
Publicado: (2018)

Cholinergic neuromuscular hyperactivity in a patient with anti-muscle-specific tyrosine kinase myasthenia gravis
por: Okhovat, Ali Asghar, et al.
Publicado: (2020)

Comment on “Detecting Key Genes Regulated by miRNAs in Dysfunctional Crosstalk Pathway of Myasthenia Gravis”
por: Le Panse, Rozen
Publicado: (2017)

Successful administration of electroconvulsive therapy in a patient with treatment-resistant schizophrenia and coexisting myasthenia gravis
por: Sreeraj, Vanteemar S., et al.
Publicado: (2019)

Progressive Bulbar Palsy with Facial Diplegia and Proximal Weakness Diagnosed as Juvenile-Onset Myasthenia Gravis
por: Verma, Rajesh, et al.
Publicado: (2023)

Myasthenia gravis
por: Juel, Vern C, et al.
Publicado: (2007)

Myasthenia Gravis
por: Aarli, Johan A., et al.
Publicado: (2011)

Myasthenia Gravis
Publicado: (1905)

Cannot write session to /tmp/vufind_sessions/sess_8f80g730dqi2rrvuf0fommacd2